Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FCMWK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,835
Award facts
- Contract value 100% obligated
- $14,834.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,834.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, represents a specific product requirement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA. The IDC, valued at $499,999,999 and valid through November 2026, enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. No set-aside designation was applied to this award.
DMS Pharmaceutical Group leverages its status as a woman-owned small business to compete effectively in federal procurement markets and has established itself as a critical supplier in the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites across the nation. This particular delivery order for Entyvio—a biologic medication used in the treatment of inflammatory bowel disease—exemplifies the company's role in providing specialized pharmaceutical products that support the medical readiness and healthcare capabilities of military installations.
Quick answers
Who was awarded contract SPE2DB25FCMWK?
SPE2DB25FCMWK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FCMWK worth?
The government has obligated $14,835 on SPE2DB25FCMWK.
Is contract SPE2DB25FCMWK an order under another contract?
Yes. SPE2DB25FCMWK is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMWK competed?
The extent of competition for SPE2DB25FCMWK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award